17-May-17 Alibaba Health Information Technology reported a massive 739% year-on-year revenue increase on the back of its pharmaceutical e-commerce business. Revenue in Ali Health’s financial year to March rose to RMB475 mn (USD69 mn) from RMB57 mn (USD8.3 mn). [image: South China Morning Post]

11-May-17 Following the price-cap placed on stents, the Indian government wants to put more medical devices under price control and proposes to change the Indian Medical Council Act to make it mandatory for doctors to prescribe generic medicines. [image: ET Healthworld]

26-Apr-17 Despite India's online pharmacy market regulatory hurdles and startups like Zigy shutting down, some investors are backing select ventures as they look to disrupt the pharma retailing industry. Bengaluru-based Myra has roped in Matrix Partners and Times Internet as investors, putting in around USD7-8 mn. Myra is planning to enter Mumbai, Delhi, Hyderbad and Pune. [image: Myra]

20-Apr-17 As China develops, it struggles to deal with wrenching healthcare challenges. It produces few breakthrough innovations in medicine and healthcare technology. New investments and policy reforms, however, could transform China into one of the top R&D hubs. The Chinese government recently enacted new programs to stimulate entrepreneurship, bolster domestic research institutions, and promote innovative approaches to upgrading the healthcare system. [image: Techonomy / Shutterstock]

10-Apr-17 Korean biotech companies are drawing much interest and investment from well-known foreign investors including Bain Capital, Goldman Sachs and the state-run Chinese company Tsinghua Tongfang Group. Korea biotech firms, according to one investor "are second to none, in terms of technology but their values have been underestimated due to the small size of the domestic market.” [image: Business Korea]